company background image
A137

SD BioSensor KOSE:A137310 Stock Report

Last Price

₩45.85k

Market Cap

₩4.6t

7D

-1.7%

1Y

n/a

Updated

09 May, 2022

Data

Company Financials +
A137310 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends4/6

A137310 Stock Overview

SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for SD BioSensor
Historical stock prices
Current Share Price₩45,850.00
52 Week High₩81,000.00
52 Week Low₩40,400.00
Beta0
1 Month Change-13.98%
3 Month Change-26.87%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-24.84%

Recent News & Updates

Shareholder Returns

A137310KR Medical EquipmentKR Market
7D-1.7%-2.5%-1.9%
1Yn/a-9.9%-15.5%

Return vs Industry: Insufficient data to determine how A137310 performed against the KR Medical Equipment industry.

Return vs Market: Insufficient data to determine how A137310 performed against the KR Market.

Price Volatility

Is A137310's price volatile compared to industry and market?
A137310 volatility
A137310 Average Weekly Movement5.7%
Medical Equipment Industry Average Movement5.6%
Market Average Movement5.5%
10% most volatile stocks in KR Market10.6%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A137310 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: A137310's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010326Hyo Keun Leehttps://www.sdbiosensor.com

SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters.

SD BioSensor Fundamentals Summary

How do SD BioSensor's earnings and revenue compare to its market cap?
A137310 fundamental statistics
Market Cap₩4.64t
Earnings (TTM)₩1.06t
Revenue (TTM)₩2.93t

4.4x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A137310 income statement (TTM)
Revenue₩2.93t
Cost of Revenue₩1.36t
Gross Profit₩1.57t
Other Expenses₩504.51b
Earnings₩1.06t

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)10.53k
Gross Margin53.56%
Net Profit Margin36.34%
Debt/Equity Ratio7.8%

How did A137310 perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

12%

Payout Ratio

Valuation

Is SD BioSensor undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


23.5%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: A137310 (₩45850) is trading below our estimate of fair value (₩59900.65)

Significantly Below Fair Value: A137310 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: A137310 is good value based on its PE Ratio (4.4x) compared to the KR Medical Equipment industry average (13x).

PE vs Market: A137310 is good value based on its PE Ratio (4.4x) compared to the KR market (14.7x).


Price to Earnings Growth Ratio

PEG Ratio: A137310's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: A137310 is good value based on its PB Ratio (2.1x) compared to the KR Medical Equipment industry average (2.6x).


Future Growth

How is SD BioSensor forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-37.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: A137310's earnings are forecast to decline over the next 3 years (-37.7% per year).

Earnings vs Market: A137310's earnings are forecast to decline over the next 3 years (-37.7% per year).

High Growth Earnings: A137310's earnings are forecast to decline over the next 3 years.

Revenue vs Market: A137310's revenue is expected to decline over the next 3 years (-28.3% per year).

High Growth Revenue: A137310's revenue is forecast to decline over the next 3 years (-28.3% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A137310's Return on Equity is forecast to be low in 3 years time (10.4%).


Past Performance

How has SD BioSensor performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


17.6%

Historical Healthcare annual earnings growth

Earnings and Revenue History

Quality Earnings: A137310 has high quality earnings.

Growing Profit Margin: Insufficient data to determine if A137310's profit margins have improved over the past year.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if A137310's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare A137310's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.

Earnings vs Industry: Insufficient data to determine if A137310's earnings growth over the past year exceeded the Medical Equipment industry average.


Return on Equity

High ROE: A137310's Return on Equity (48.3%) is considered outstanding.


Financial Health

How is SD BioSensor's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A137310's short term assets (₩2,578.0B) exceed its short term liabilities (₩779.9B).

Long Term Liabilities: A137310's short term assets (₩2,578.0B) exceed its long term liabilities (₩21.9B).


Debt to Equity History and Analysis

Debt Level: A137310 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A137310's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A137310's debt is well covered by operating cash flow (722.3%).

Interest Coverage: A137310 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is SD BioSensor current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.76%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: A137310's dividend (2.76%) is higher than the bottom 25% of dividend payers in the KR market (0.83%).

High Dividend: A137310's dividend (2.76%) is in the top 25% of dividend payers in the KR market (2.69%)


Stability and Growth of Payments

Stable Dividend: Too early to tell whether A137310's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if A137310's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (11.6%), A137310's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (12.3%), A137310's dividend payments are thoroughly covered by cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Hyo Keun Lee

no data

Tenure

Hyo Keun Lee is Vice Chairman and Chief Executive Officer of SD BioSensor, Inc.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: A137310 only recently listed within the past 12 months.


Top Shareholders

Company Information

SD BioSensor, Inc's employee growth, exchange listings and data sources


Key Information

  • Name: SD BioSensor, Inc
  • Ticker: A137310
  • Exchange: KOSE
  • Founded: 2010
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: ₩4.637t
  • Shares outstanding: 101.14m
  • Website: https://www.sdbiosensor.com

Number of Employees


Location

  • SD BioSensor, Inc
  • 16 Deokyeong-daero
  • 4th and 5th Floors
  • Suwon
  • Gyeonggi-do
  • 16690
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/09 00:00
End of Day Share Price2022/05/09 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.